Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his department has considered the impact of NICE’s severity modifier, introduced in 2020, on NHS England’s access to innovative cancer medicines which were previously eligible under the end-of-life weighting.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended to make NICE’s methods fairer, faster and more consistent.
NICE carried out a review of the implementation of the severity modifier in September 2024 and found that it is operating as intended with a greater proportion of medicines recommended than under NICE’s previous methods. Since then, NICE has continued to monitor how the severity modifier is being applied. The latest figures include data from technology appraisals published up until the end of September 2025 and show that the proportion of positive decisions has increased since the severity modifier was implemented and since data was published in September 2024. 87.0% of decisions taken since the severity modifier was implemented, compared with 82.5% when the end-of-life modifier was being used. NICE is also recommending a greater proportion of new cancer treatments overall, 86.3% compared to 75.0%, and advanced cancer treatments specifically, 84.8% compared to 69.1%.
NICE has commissioned research to gather further evidence on societal preferences that will inform future methods reviews.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department made an impact assessment of the effect of NICE’s severity modifier, introduced in 2020, on the ability of cancer medicines to meet the new ‘high severity’ threshold for approval.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended to make NICE’s methods fairer, faster and more consistent.
NICE carried out a review of the implementation of the severity modifier in September 2024 and found that it is operating as intended with a greater proportion of medicines recommended than under NICE’s previous methods. Since then, NICE has continued to monitor how the severity modifier is being applied. The latest figures include data from technology appraisals published up until the end of September 2025 and show that the proportion of positive decisions has increased since the severity modifier was implemented and since data was published in September 2024. 87.0% of decisions taken since the severity modifier was implemented, compared with 82.5% when the end-of-life modifier was being used. NICE is also recommending a greater proportion of new cancer treatments overall, 86.3% compared to 75.0%, and advanced cancer treatments specifically, 84.8% compared to 69.1%.
NICE has commissioned research to gather further evidence on societal preferences that will inform future methods reviews.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has assessed whether NICE has approved a greater or fewer number of new medicines since the introduction of the severity modifier in 2020, compared with comparable international health systems.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended to make NICE’s methods fairer, faster and more consistent.
NICE carried out a review of the implementation of the severity modifier in September 2024 and found that it is operating as intended with a greater proportion of medicines recommended than under NICE’s previous methods. Since then, NICE has continued to monitor how the severity modifier is being applied. The latest figures include data from technology appraisals published up until the end of September 2025 and show that the proportion of positive decisions has increased since the severity modifier was implemented and since data was published in September 2024. 87.0% of decisions taken since the severity modifier was implemented, compared with 82.5% when the end-of-life modifier was being used. NICE is also recommending a greater proportion of new cancer treatments overall, 86.3% compared to 75.0%, and advanced cancer treatments specifically, 84.8% compared to 69.1%.
NICE has commissioned research to gather further evidence on societal preferences that will inform future methods reviews.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, how many households where (a) Pension Credit and (b) Housing Benefit is claimed receive additional consideration due to there being a polygamous marriage.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
Since 1988 rules have been in place under successive governments which limit access to benefits for people in polygamous marriages to those who were married in a country which allows such marriages. Any polygamous relationship formed in the United Kingdom is excluded by these rules and the second or subsequent partner is treated as a non-dependant. People in polygamous relationships where they are not married to the other members of the relationship are also excluded by these rules.
Where a claimant is allowed to claim benefits as part of a polygamous marriage their benefit entitlement is based on the standard amount for couples, plus an amount for each additional partner calculated as the difference between the standard amount for a couple and the standard amount for a single person. There is no financial benefit to someone claiming as part of a polygamous marriage as more would be paid in benefits if the additional person claimed as a single person.
The Pension Credit information that has been requested is not held by the Department. Based off the most recent published data (August 2025) from the Housing Benefit Single Housing Extract (SHBE), there are fewer than ten households where the claimant is recorded as having more than one partner. This has been used as a proxy for polygamous marriage.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department for Education:
To ask the Secretary of State for Education, what assessment she has made of the adequacy of the accessibility of information provided by English universities on entry requirements for Scottish Highers and Advanced Highers on their websites.
Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)
Universities are autonomous bodies, independent from government and are responsible for their own admissions decisions.
Universities are free to decide their entry criteria, and admissions teams consider a broad range of information about a student in addition to their predicted grades.
The department continues to work with key sector stakeholders such as higher education providers, UCAS and Universities UK to ensure that students have access to a comprehensive wealth of information, advice and guidance, allowing them to make fully informed and appropriate decisions on course and provider choice.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Home Office:
To ask the Secretary of State for the Home Department, what steps she is taking to increase collaboration between her Department and Drinkaware.
Answered by Sarah Jones - Minister of State (Home Office)
The Government regularly engages with partners on matters relating to the Licensing Act 2003 and the sale and supply of alcohol, including with Drinkaware.
We will continue to do so as we take forward reforms to the licensing regime.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the (a) findings of and (b) recommendation on alcohol and breast cancer in the World Cancer Research Fund's 2025 report entitled Dietary and Lifestyle Patterns for Cancer Prevention: Evidence and Recommendations from CUP Global.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government and the National Health Service recognise that a healthy lifestyle can help reduce the biggest risk factors of certain cancers. The Government welcomes the recent publication of the World Cancer Research Fund's 2025 report.
The UK Chief Medical Officers’ low-risk drinking guidelines and the NHS webpage on the risks of alcohol, clearly state that alcohol consumption can increase the risk of developing seven types of cancer, including breast cancer.
The National Disease Registration Service (NDRS) collects patient data on cancer, congenital anomalies and rare diseases. The NDRS does not collect data on the causes of cancer. Therefore, the Department has not made a formal assessment on the annual cost to the NHS of treating breast cancer cases in the United Kingdom that are attributable to alcohol consumption.
The National Cancer Plan for England, which will be published in the new year, will build on the shift from sickness to prevention set out by the 10-Year Health Plan and will seek to reduce risk factors. The plan will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as prevention. This will include alcohol consumption, alongside other risk factors, given alcohol is linked to an increased risk of seven types of cancer, including breast cancer.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many breast cancer cases in the UK are estimated to be caused by alcohol consumption each year; and what percentage of total breast cancer cases this represents.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government and the National Health Service recognise that a healthy lifestyle can help reduce the biggest risk factors of certain cancers. The Government welcomes the recent publication of the World Cancer Research Fund's 2025 report.
The UK Chief Medical Officers’ low-risk drinking guidelines and the NHS webpage on the risks of alcohol, clearly state that alcohol consumption can increase the risk of developing seven types of cancer, including breast cancer.
The National Disease Registration Service (NDRS) collects patient data on cancer, congenital anomalies and rare diseases. The NDRS does not collect data on the causes of cancer. Therefore, the Department has not made a formal assessment on the annual cost to the NHS of treating breast cancer cases in the United Kingdom that are attributable to alcohol consumption.
The National Cancer Plan for England, which will be published in the new year, will build on the shift from sickness to prevention set out by the 10-Year Health Plan and will seek to reduce risk factors. The plan will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as prevention. This will include alcohol consumption, alongside other risk factors, given alcohol is linked to an increased risk of seven types of cancer, including breast cancer.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase levels of public awareness on the potential impact of alcohol consumption on levels of breast cancer risk.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government and the National Health Service recognise that a healthy lifestyle can help reduce the biggest risk factors of certain cancers. The Government welcomes the recent publication of the World Cancer Research Fund's 2025 report.
The UK Chief Medical Officers’ low-risk drinking guidelines and the NHS webpage on the risks of alcohol, clearly state that alcohol consumption can increase the risk of developing seven types of cancer, including breast cancer.
The National Disease Registration Service (NDRS) collects patient data on cancer, congenital anomalies and rare diseases. The NDRS does not collect data on the causes of cancer. Therefore, the Department has not made a formal assessment on the annual cost to the NHS of treating breast cancer cases in the United Kingdom that are attributable to alcohol consumption.
The National Cancer Plan for England, which will be published in the new year, will build on the shift from sickness to prevention set out by the 10-Year Health Plan and will seek to reduce risk factors. The plan will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as prevention. This will include alcohol consumption, alongside other risk factors, given alcohol is linked to an increased risk of seven types of cancer, including breast cancer.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the annual cost to the NHS of treating breast cancer cases in the UK that are attributable to alcohol consumption.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government and the National Health Service recognise that a healthy lifestyle can help reduce the biggest risk factors of certain cancers. The Government welcomes the recent publication of the World Cancer Research Fund's 2025 report.
The UK Chief Medical Officers’ low-risk drinking guidelines and the NHS webpage on the risks of alcohol, clearly state that alcohol consumption can increase the risk of developing seven types of cancer, including breast cancer.
The National Disease Registration Service (NDRS) collects patient data on cancer, congenital anomalies and rare diseases. The NDRS does not collect data on the causes of cancer. Therefore, the Department has not made a formal assessment on the annual cost to the NHS of treating breast cancer cases in the United Kingdom that are attributable to alcohol consumption.
The National Cancer Plan for England, which will be published in the new year, will build on the shift from sickness to prevention set out by the 10-Year Health Plan and will seek to reduce risk factors. The plan will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as prevention. This will include alcohol consumption, alongside other risk factors, given alcohol is linked to an increased risk of seven types of cancer, including breast cancer.